CIK 0001022899
- Non-accelerated filer
- Smaller reporting company
Protagenic Therapeutics, Inc.\new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061390025
- Phone
- +1 212-994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- DEF 14A Proxy Proxy Statement
Page 1 of 4 · 79 filings